RetractedArticleOncology letters2018

Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway.

Dongjie Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.